位置:成果数据库 > 期刊 > 期刊详情页
基于HPV16的新型伪病毒治疗MRL/lpr小鼠狼疮性肾炎的实验研究
  • ISSN号:1672-9463
  • 期刊名称:《中国现代医药杂志》
  • 时间:0
  • 分类:R339.38[医药卫生—人体生理学;医药卫生—基础医学] R593.242[医药卫生—临床医学;医药卫生—内科学]
  • 作者机构:[1]第三军医大学基础部全军免疫研究所,重庆400038
  • 相关基金:国家自然科学基金资助项目(30400215)
中文摘要:

目的 构建基于人乳头状病毒(human papilloma virus,HPV)16型的新型伪病毒,探讨对MRL/lpr小鼠狼疮性肾炎的治疗作用,为临床治疗系统性红斑狼疮提供实验依据。方法 将12只3月龄MRL/lpr狼疮小鼠随机均分为治疗组和对照组,治疗前后测定尿蛋白、血清尿素氮、肌酐及抗ds-DNA抗体滴度。结果 治疗组小鼠治疗后的尿蛋白、血清尿素氮、肌酐及抗ds-DNA抗体均下降,与治疗前有显著性差异(P〈0.05),而对照组治疗前后无显著性差异(P〉0.05),并且治疗组小鼠的平均生存期比对照组明显延长(P〈0.05)。结论 基于人乳头状病毒16型的新型伪病毒可显著改善MRL/lpr小鼠的免疫状况和肾脏功能,提高平均生存期。该研究结果 为临床治疗系统性红斑狼疮提供了新的启示。

英文摘要:

Objective To construct pseudovirus based on human papilloma virus type 16 (HPV16) and explore the treatment effect of lupus nephritis in MRL/lpr lupus mice, which may provide experimental evidence for the treatment of systemic lupus efythematosus (SLE). Methods Twelve 3-month-old MRL/lpr lupus mice were divided into treatment and control groups. The amount of urinary protein, serum creatinine level, and anti-dsDNA antibody were measured before and after treatment. Results The amount of urinary protein, serum creatinine level, and anti-dsDNA antibody after treatment were significant lower than that of before treatment in the treatment group; however, these data had no significant change in the control group. In addition, the survival of treatment group was prolonged compared with control group. Conclusion The pseudovirus based on human papilloma virus type 16 can improve immune status, renal function of MRL/lpr lupus mice and improve their lives, which may provide new clues for the therapy of SLE.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国现代医药杂志》
  • 主管单位:中国航天科技集团公司
  • 主办单位:北京航天总医院
  • 主编:王建国
  • 地址:北京市丰台区万源北路7号
  • 邮编:100076
  • 邮箱:Bixiangz2002@263.net
  • 电话:010-68383759
  • 国际标准刊号:ISSN:1672-9463
  • 国内统一刊号:ISSN:11-5248/R
  • 邮发代号:82-958
  • 获奖情况:
  • 国内外数据库收录:
  • 被引量:15301